Zhang Y, Lai W-P, Wu C-F, Favus MJ, Leung P-C, Wong M-S. Ovariectomy worsens secondary hyperparathyroidism in mature rats during low-Ca diet. Am J Physiol Endocrinol Metab 292: E723-E731, 2007. First published October 31, 2006; doi:10.1152/ajpendo.00445.2006.-Estrogen deficiency impairs intestinal Ca absorption and induces bone loss, but its effects on the vitamin D-endocrine system are unclear. In the present study, calciotropic hormones levels, renal vitamin D metabolism, 1,25-dihydroxyvitamin D3 [1,25(OH)2D3]-dependent intestinal calcium absorption, and bone properties in 3-mo-old sham-operated (sham) or ovariectomized (OVX) rats fed either a normal-Ca (NCD; 0.6% Ca, 0.65% P) or a low-Ca (LCD; 0.1% Ca, 0.65% P) diet for 2 wk were determined. LCD increased serum 1,25(OH)2D3 levels in both sham and OVX rats. Serum parathyroid hormone [PTH(1-84)] levels were highest in OVX rats fed LCD. Renal 25-hydroxyvitamin D1␣-hydroxylase (1-OHase) protein expression was induced in both sham and OVX rats during LCD, while renal 1-OHase mRNA expression was highest in OVX rats fed LCD. Renal vitamin D receptor (VDR) and mRNA expressions in rats were induced by ovariectomy in rats fed NCD but suppressed by ovariectomy in rats fed LCD. The induction of intestinal calcium transporter-1 and calbindin-D9k mRNA expressions by LCD were not altered by ovariectomy. As expected, bone Ca content, cancellous bone mineral density, and bone strength index in proximal metaphysis of rat tibia were reduced by both ovariectomy and LCD (P Ͻ 0.05) as analyzed by two-way ANOVA. Taken together, the data demonstrate that ovariectomy alters the responses of circulating PTH levels, renal 1-OHase mRNA expression, and renal VDR expression to LCD. These results suggest that estrogen is necessary for the full adaptive response to LCD mediated by both PTH and 1,25(OH)2D3. parathyroid hormone ; renal vitamin D receptor; renal 25-hydroxyvitamin D1␣-hydroxylase; dietary Ca restriction THE IMPAIRMENT OF INTESTINAL Ca absorption in humans (19,23,35,39) and in rats (2, 9, 26, 29) and induction of bone turnover (1,15,30) by estrogen deficiency are believed to contribute to negative Ca balance and bone loss during menopause. The cause of the impairment of intestinal Ca absorption by estrogen deficiency has been attributed to either a decrease in serum 1,25-dihydroxyvitamin D 3 [1,25(OH) 2 D 3 ] levels (9, 16, 39) or a direct effect of estrogen on intestinal Ca transport (3,9,14,26). During menopause, the increased Ca requirements due to poor intestinal absorption and increased urinary loss are complicated by the age-related abnormalities of the vitamin Dendocrine system, including secondary hyperparathyroidism, intestinal resistance to 1,25(OH) 2 D 3 , and decreased 1,25(OH) 2 D 3 production due to impaired 25-hydroxyvitamin D1␣-hydroxylase (1-OHase) activity (37,38). Although the effects of menopause and estrogen on circulating levels of 1,25(OH) 2 D 3 in postmenopausal women have been reported (13,36), it is still unclear whether estrogen deficiency interferes ...